DexCom Inc. (NASDAQ:DXCM) is a top growth stock on NASDAQ. Analysts anticipate strong Q3 results in the MedTech sector, driven by continuous glucose monitors and insulin pumps.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Truist Lowers DexCom (DXCM) PT to $94 Ahead of Q3 MedTech Sector Preview, Maintains Buy Rating
